Chromatographic purity
[NOTEUse low-actinic glassware throughout this procedure,and otherwise protect the test specimen,the Reference Standard,and all solutions containing them from unnecessary exposure to light.
]
Mobile phase
Prepare as directed in the
Assay.
Standard solution
Dissolve an accurately weighed quantity of
USP Isradipine RSin
Mobile phase,with the aid of sonication if necessary,and dilute quantitatively and stepwise with
Mobile phaseto obtain a solution having a known concentration of about 6µg per mL.
[NOTEIf necessary,use 1mLof methanol per 20mLof
Mobile phase to dissolve the Reference Standard prior to diluting with
Mobile phase.
]
Resolution solution
Use the
Standard preparationprepared as directed in the
Assay.
Test solution
Transfer about 50mg of Isradipine,accurately weighed,to a 25-mLvolumetric flask,and add 5.0mLof methanol to dissolve,using sonication if necessary.Dilute with Mobile phaseto volume,and mix.
Chromatographic system
(see
Chromatography á621ñ)The liquid chromatograph is equipped with a 230-nm detector and a 4.6-mm ×10-cm column that contains packing L1.The flow rate is about 1.7mLper minute.Chromatograph replicate injections of the
Resolution solution,and record the peak responses as directed under
Procedure:the resolution,
R,between isradipine and isradipine related compound Ais not less than 1.5,and the relative standard deviation for replicate injections is not more than 1.5%.
Procedure
Separately inject equal volumes (about 25µL)of the Standard solutionand the Test solutioninto the chromatograph,and allow the Test solutionto elute for not less than three times the retention time of isradipine.Record the chromatograms,and measure the responses for all of the peaks:the sum of the peak responses,other than that of isradipine,in the chromatogram of the Test solutionis not more than four times the isradipine response obtained from the Standard solution(1.2%),the response of the largest peak,other than that of isradipine,in the chromatogram of the Test solutionis not more than 1.6times greater than the isradipine response obtained from the Standard solution(0.5%),and no other peak response,other than that of isradipine,is greater than the isradipine response obtained from the Standard solution(0.3%).
Assay
[NOTEUse low-actinic glassware throughout this procedure,and otherwise protect the test specimen,the Reference Standard,and all solutions containing them,from unnecessary exposure to light.
]
Mobile phase
Prepare a filtered and degassed mixture of water,methanol,and tetrahydrofuran (50:40:10).Make adjustments,if necessary (see
System Suitabilityunder
Chromatography á621ñ).
Standard preparation
Dissolve,with the aid of sonication,if necessary,accurately weighed quantities of
USP Isradipine RSand
USP Isradipine Related Compound A RSin
Mobile phase,and dilute quantitatively,and stepwise,if necessary,with
Mobile phaseto obtain a solution having known concentrations of 0.2mg and 10µg of
USP Isradipine RSand
USP Isradipine Related Compound A RS,respectively,per mL.
[NOTEIf necessary,1mLof methanol per 20mLof
Mobile phase may be added to dissolve the Reference Standards.
]
Assay preparation
Transfer about 20mg of Isradipine,accurately weighed,to a 100-mLvolumetric flask.Add sufficient methanol to dissolve,using sonication,if necessary.Dilute with Mobile phaseto volume,and mix.
Chromatographic system
(see
Chromatography á621ñ)The liquid chromatograph is equipped with a 326-nm detector and a 4.6-mm ×10-cm column that contains packing L1.The flow rate is about 1.7mLper minute.Chromatograph the
Standard preparation,and record the peak responses as directed under
Procedure:the resolution,
R,between isradipine and isradipine related compound Ais not less than 1.5,and the relative standard deviation for replicate injections is not more than 1.5%.
Procedure
Separately inject equal volumes (about 25µL)of the
Standard preparationand the
Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.Calculate the quantity,in mg,of C
19H
21N
3O
5in the portion of Isradipine taken by the formula:
100C(rU/rS),
in which
Cis the concentration,in mg per mL,of
USP Isradipine RSin the
Standard preparation,and
rUand
rSare the isradipine peak responses obtained from the
Assay preparationand the
Standard preparation,respectively.